Biotechnology Stockmarket Biotech

Biotech Stock in News: Alexion Beats on Earnings & Revenues in Q3

Alexion Pharmaceuticals’ (ALXN) third-quarter 2014 earnings (including stock-based compensation expense) of $1.14 per share beat the Zacks Consensus Estimate by 9 cents. The earnings beat was attributable to higher-than-expected revenues. Moreover, earnings were above the year-ago figure by 56.2%. Including one-time items, Alexion’s earnings climbed 87% year over year to 88 cents per share in…

Read More

Major Stock News: Another Round Of Microsoft (NASDAQ MSFT) Layoffs

According to knowledgeable sources, Microsoft Corporation (NASDAQ MSFT) is laying off its entire global advertising sales team. The reduction in force comes as the ad sales positions have become largely redundant as individual divisions are handling their own ad sales today. The sources note the layoffs are coming within the Microsoft Advertising division, and are…

Read More